New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454

[1]  B. Roques,et al.  Development of new potent agonists able to interact with two postulated subsites of the cholecystokinin CCK-B receptor , 1997, Letters in Peptide Science.

[2]  A. Puech,et al.  Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats , 1995, Psychopharmacology.

[3]  J. Féger,et al.  Opioid δ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area , 2005, Psychopharmacology.

[4]  C. Garbay,et al.  Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties. , 2004, Bioorganic & medicinal chemistry letters.

[5]  B. Maigret,et al.  Computer modelling of new pseudopeptide CCK2 agonists , 2002 .

[6]  C. Garbay,et al.  Heterogeneity of Cholecystokinin Receptors: A New Interest Towards the Development of CCK2 Agonists , 2001 .

[7]  D. Goletti,et al.  Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis. , 2001, Current molecular medicine.

[8]  B. Maigret,et al.  Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode. , 2000, Journal of medicinal chemistry.

[9]  Bruno Bellier.  Hétérogénéité fonctionnelle du récepteur CCK2 à la cholecystokinine : conception, étude de nouveaux outils pharmacologiques et perspectives thérapeutiques associées , 2000 .

[10]  C. Garbay,et al.  Involvement of D2 dopamine receptors in the opposing effects of two CCK-B agonists in a spatial recognition memory task: role of the anterior nucleus accumbens , 2000, Psychopharmacology.

[11]  B. Roques,et al.  Rat Hippocampal Neurons Are Critically Involved in Physiological Improvement of Memory Processes Induced by Cholecystokinin-B Receptor Stimulation , 1999, The Journal of Neuroscience.

[12]  B. Roques,et al.  Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the ∂ opioid system in the nucleus accumbens of rat , 1999, Neuropharmacology.

[13]  B. Roques,et al.  CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology , 1999, Progress in Neurobiology.

[14]  F Noble,et al.  The CholecystokininB Receptor Is Coupled to Two Effector Pathways Through Pertussis Toxin‐Sensitive and ‐Insensitive G Proteins , 1999, Journal of neurochemistry.

[15]  H. Simon,et al.  Opposing effects of two CCKB agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat , 1999, Neuropharmacology.

[16]  J. Black,et al.  Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex , 1999, British journal of pharmacology.

[17]  I. Léna,et al.  CCK in Anxiety and Cognitive Processes , 1998, Neuroscience & Biobehavioral Reviews.

[18]  B. Roques,et al.  Opposite effects of CCKB agonists in grooming behaviour in rats: further evidence for two CCKB subsites , 1998 .

[19]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[20]  B. Roques,et al.  Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites. , 1998, British journal of pharmacology.

[21]  B. Roques,et al.  Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells. , 1997, Journal of medicinal chemistry.

[22]  B. Roques,et al.  The CCK‐B Agonist, BC264, Increases Dopamine in the Nucleus Accumbens and Facilitates Motivation and Attention After lntraperitoneal Injection in Rats , 1997, The European journal of neuroscience.

[23]  M. Le Moal,et al.  Extension of a New Two-Trial Memory Task in the Rat: Influence of Environmental Context on Recognition Processes , 1997, Neurobiology of Learning and Memory.

[24]  B. Roques,et al.  Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. , 1997, Journal of medicinal chemistry.

[25]  B. Roques,et al.  Dual Modulation of Dopamine Release from Anterior Nucleus Accumbens Through Cholecystokinin‐B Receptor Subsites , 1997, Journal of neurochemistry.

[26]  H. Westenberg,et al.  Cholecystokinin in anxiety , 1996, European Neuropsychopharmacology.

[27]  B. Roques,et al.  Novel CCK-B receptor agonists: diketopiperazine analogues derived from CCK4 bioactive conformation , 1996, Regulatory Peptides.

[28]  J. Black,et al.  Analysis of variation in L‐365,260 competition curves in radioligand binding assays , 1996, British journal of pharmacology.

[29]  C. Owyang,et al.  Structural requirements of CCK analogues to differentiate second messengers and pancreatic secretion. , 1996, The American journal of physiology.

[30]  T. Kenakin.  RECEPTOR CONFORMATIONAL INDUCTION VERSUS SELECTION : ALL PART OF THE SAME ENERGY LANDSCAPE , 1996 .

[31]  T. Kenakin,et al.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.

[32]  Jacqueline N. Crawley,et al.  Biological actions of cholecystokinin , 1994, Peptides.

[33]  S. Wank,et al.  Multiple affinity states of different cholecystokinin receptors. , 1994, The Journal of biological chemistry.

[34]  B. Roques,et al.  Heterogeneity of CCK-B receptors involved in animal models of anxiety , 1994, Pharmacology Biochemistry and Behavior.

[35]  B. Roques,et al.  Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats , 1993, Brain Research.

[36]  G. P. Smith,et al.  Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats , 1992, Pharmacology Biochemistry and Behavior.

[37]  M. Le Moal,et al.  A two-trial memory task with automated recording: study in young and aged rats , 1992, Brain Research.

[38]  V. Hruby,et al.  A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity. , 1990, The Journal of pharmacology and experimental therapeutics.

[39]  B. Costall,et al.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Bali,et al.  ACE-like hydrolysis of gastrin analogs and CCK-8 by fundic mucosal cells of different species with release of the amidated C-terminal dipeptide. , 1990, Biochimica et biophysica acta.

[41]  J. Soar,et al.  L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity , 1989, Pharmacology Biochemistry and Behavior.

[42]  J. Féger,et al.  The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat. , 1989, European journal of pharmacology.

[43]  R. Chang,et al.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. , 1989, European journal of pharmacology.

[44]  B. Roques,et al.  Enzyme-resistant CCK analogs with high affinities for central receptors , 1988, Peptides.

[45]  S. Iversen,et al.  Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. , 1988, European journal of pharmacology.

[46]  P. Portoghese,et al.  Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist , 1988 .

[47]  B. Roques,et al.  Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties. , 1987, Journal of Medicinal Chemistry.

[48]  R. Chang,et al.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. Roques,et al.  Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex. , 1986, Biochemical and biophysical research communications.